local_hospital

Iaso Thessalia General Clinic Private Obstetrics S.A.

Address
lock Available on a paid plan

Eye Diseases and Diagnostic Techniques

At Iaso Thessalia General Clinic Private Obstetrics S.A., research in ophthalmology focuses on glaucoma, ocular hypertension, and related eye conditions. These studies are designed to compare established and newer eye drop treatments, while also supporting better approaches to diagnosis and pupil dilation for clinical use.

  • Testing new generic eye drop combinations for open-angle glaucoma and ocular hypertension
  • Evaluating treatment effectiveness by measuring changes in intraocular pressure
  • Studying mydriatic eye drops to support pre-operative and diagnostic eye care

This area of research aims to improve everyday eye care by confirming whether alternative formulations can perform as well as reference treatments and help protect vision.

Cardiovascular Disease and Heart Failure

The site also supports research in cardiovascular diseases, with a focus on heart failure with preserved ejection fraction and heart failure with mildly reduced ejection fraction in people living with obesity. These trials are looking at whether a new therapy can lower the risk of serious heart-related events when added to standard care.

  • Studying heart failure outcomes in patients with obesity
  • Assessing whether treatment can reduce hospitalisation and urgent care visits
  • Comparing a new therapy with placebo alongside standard treatment

This work is aimed at improving long-term management of complex heart failure, especially where weight-related health issues may add to the burden of disease.

Autoimmune and Inflammatory Disease Research

Clinical research at the clinic also includes systemic lupus erythematosus, a chronic autoimmune disease that can affect multiple organs. The trial activity in this area is focused on evaluating a new treatment option to better control disease activity when used with standard care.

  • Investigating treatment effectiveness in systemic lupus erythematosus
  • Measuring changes in overall disease activity
  • Exploring whether a new therapy may improve care for patients with active disease

This research reflects an effort to expand options for people living with a complex autoimmune condition that often requires careful, ongoing management.

Site Overview

assignment
7
connected trials
corporate_fare
6
sponsors
science
13
IMPs

Activity Indicator

Last 6 months

2
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
7
Total trials linked
Active
trending_upGrowing+100%
1
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
6
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 173 other sites in Greece

description
Trial volume
7
Outperforms 62% of sites
public
Therapeutic diversity
5areas
Outperforms 70% of sites
groups
Sponsor diversity
6sponsors
Outperforms 64% of sites

Therapeutic Area Benchmark — Greece

Select a therapeutic area to compare against other sites in Greece.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Greece

Market Share

Country: Greece

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Iaso Thessalia General Clinic Private Obstetrics S.A.

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Non-Inferiority Study Comparing Brimonidine Tartrate and Timolol Fixed-Dose Combination Eye Drops to an Active Comparator in Patients with Open-Angle Glaucoma or Ocular HypertensionOmniVision GmbHPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 13 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Brimonidine Tartrate2Unknown2024-05-312024-05-31

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.